Nutra Pharma Corp (NPHC) stock
NPHCOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
$0.00+0.00 (0.00%)
Close on Oct 19, 2026Market cap $806.69KP/E –Yield –
Nutra Pharma total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Nutra Pharma's total debt was $12.57M at Jun 30, 2026. For fiscal 2025 it was $9.76M, up 13.1% from the year before. Over ten years it grew 15.6% a year on average. The highest annual figure on record is $9.76M in fiscal 2025.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $9.76M | +13.1% |
| FY2024 | Dec 31, 2024 | $8.63M | +1.9% |
| FY2023 | Dec 31, 2023 | $8.47M | +4.8% |
| FY2022 | Dec 31, 2022 | $8.08M | +4.3% |
| FY2021 | Dec 31, 2021 | $7.75M | +59.9% |
| FY2020 | Dec 31, 2020 | $4.85M | -34.1% |
| FY2019 | Dec 31, 2019 | $7.35M | +354.5% |
| FY2018 | Dec 31, 2018 | $1.62M | +137.2% |
| FY2017 | Dec 31, 2017 | $682.10K | -23.3% |
| FY2016 | Dec 31, 2016 | $888.75K | -61.1% |
| FY2015 | Dec 31, 2015 | $2.28M | +89.3% |
| FY2014 | Dec 31, 2014 | $1.21M | -37.3% |
| FY2013 | Dec 31, 2013 | $1.92M | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $12.57M | +32.6% |
| Q1 FY2026 | Mar 31, 2026 | $10.01M | +10.5% |
| Q4 FY2025 | Dec 31, 2025 | $9.76M | +13.1% |
| Q3 FY2025 | Sep 30, 2025 | $9.67M | +14.7% |
| Q2 FY2025 | Jun 30, 2025 | $9.48M | +12.1% |
| Q1 FY2025 | Mar 31, 2025 | $9.06M | +7.9% |
| Q4 FY2024 | Dec 31, 2024 | $8.63M | +1.9% |
| Q3 FY2024 | Sep 30, 2024 | $8.43M | +0.9% |
| Q2 FY2024 | Jun 30, 2024 | $8.46M | +1.5% |
| Q1 FY2024 | Mar 31, 2024 | $8.39M | +2.5% |
| Q4 FY2023 | Dec 31, 2023 | $8.47M | +4.8% |
| Q3 FY2023 | Sep 30, 2023 | $8.36M | +4.3% |
| Q2 FY2023 | Jun 30, 2023 | $8.33M | -0.9% |
| Q1 FY2023 | Mar 31, 2023 | $8.19M | +14.3% |
| Q4 FY2022 | Dec 31, 2022 | $8.08M | +4.3% |
| Q3 FY2022 | Sep 30, 2022 | $8.01M | +1.1% |
| Q2 FY2022 | Jun 30, 2022 | $8.41M | -2.1% |
| Q1 FY2022 | Mar 31, 2022 | $7.17M | -17.3% |
| Q4 FY2021 | Dec 31, 2021 | $7.75M | +59.9% |
| Q3 FY2021 | Sep 30, 2021 | $7.92M | +3588.9% |
| Q2 FY2021 | Jun 30, 2021 | $8.59M | +3898.6% |
| Q1 FY2021 | Mar 31, 2021 | $8.67M | +17.9% |
| Q4 FY2020 | Dec 31, 2020 | $4.85M | +352.5% |
| Q3 FY2020 | Sep 30, 2020 | $214.80K | -84.4% |
| Q2 FY2020 | Jun 30, 2020 | $214.80K | -86.7% |
| Q4 FY2019 | Dec 31, 2019 | $7.35M | +918.0% |
| Q2 FY2019 | Jun 30, 2019 | $1.07M | -4.1% |
| Q1 FY2019 | Mar 31, 2019 | $1.38M | +39.4% |
| Q4 FY2018 | Dec 31, 2018 | $1.62M | +137.2% |
| Q3 FY2018 | Sep 30, 2018 | $722.32K | +5.7% |
| Q2 FY2018 | Jun 30, 2018 | $1.12M | -5.7% |
| Q1 FY2018 | Mar 31, 2018 | $989.82K | +11.4% |
| Q4 FY2017 | Dec 31, 2017 | $682.10K | -15.7% |
| Q3 FY2017 | Sep 30, 2017 | $683.11K | -73.2% |
| Q1 FY2017 | Mar 31, 2017 | $1.18M | – |
| Q4 FY2016 | Dec 31, 2016 | $888.75K | – |
| Q2 FY2016 | Jun 30, 2016 | $808.89K | – |
| Q1 FY2016 | Mar 31, 2016 | $2.55M | – |
See a number that looks wrong?